Publication | Closed Access

Shikonin and chitosan-silver nanoparticles synergize against triple-negative breast cancer through RIPK3-triggered necroptotic immunogenic cell death

NanoparticlesNanomedicineEngineeringTherapeutic NanomaterialsImmunologyCell DeathChitosan-silver NanoparticlesNano-drug DeliveryTumor TargetingTriple-negative Breast CancerImmunotherapyMedicineCell BiologyTumor MicroenvironmentCancer ResearchNecroptosis